O
PRQR icon

OrbiMed’s ProQR Therapeutics PRQR Stock Holding History

OrbiMed’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,382,502
Closed -$12.6M – 133
2019
Q2 		$12.6M Sell
1,382,502
-599,529
-30% -$7.07M 0.19% 85
2019
Q1 		$27.5M Buy
1,982,031
+544,300
+38% +$8.13M 0.43% 60
2018
Q4 		$22.7M Sell
1,437,731
-600,144
-29% -$11M 0.42% 64
2018
Q3 		$39.4M Buy
2,037,875
+734,920
+56% +$7.81M 0.48% 62
2018
Q2 		$9.51M Hold
1,302,955
– – 0.11% 111
2018
Q1 		$4.01M Hold
1,302,955
– – 0.05% 121
2017
Q4 		$4.2M Sell
1,302,955
-992,391
-43% -$3.56M 0.05% 118
2017
Q3 		$11.1M Sell
2,295,346
-10,100
-0.4% -$52.4K 0.11% 105
2017
Q2 		$12M Hold
2,305,446
– – 0.13% 96
2017
Q1 		$11.5M Hold
2,305,446
– – 0.13% 90
2016
Q4 		$11.3M Hold
2,305,446
– – 0.14% 88
2016
Q3 		$15.4M Hold
2,305,446
– – 0.18% 85
2016
Q2 		$11.2M Hold
2,305,446
– – 0.12% 90
2016
Q1 		$11.3M Buy
2,305,446
+33,946
+1% +$173K 0.12% 87
2015
Q4 		$19.7M Buy
2,271,500
+430,100
+23% +$4.95M 0.18% 70
2015
Q3 		$26.8M Buy
1,841,400
+10,000
+0.5% +$167K 0.27% 65
2015
Q2 		$30.5M Hold
1,831,400
– – 0.26% 70
2015
Q1 		$40.1M Buy
1,831,400
+2,000
+0.1% +$41.3K 0.34% 59
2014
Q4 		$39.6M Buy
1,829,400
+879,400
+93% +$13.3M 0.38% 57
2014
Q3 		$16.3M Buy
+950,000
New +$15.2M 0.17% 83

Other funds holding PRQR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

OrbiMed's PRQR Position: Q3 2019 in Review

OrbiMed sold out of ProQR Therapeutics (PRQR) in Q3 2019, closing a stake of 1,382,502 shares — an estimated $12.6M sold.

OrbiMed first reported a position in PRQR in Q3 2014 and held it in 20 quarters. The position peaked at $40.1M in Q1 2015. 50 funds tracked by Wall St. Rank hold PRQR as of Q3 2019.

  • OrbiMed reported no remaining ProQR Therapeutics position as of Q3 2019 after selling out during the quarter.
  • OrbiMed sold 1,382,502 ProQR Therapeutics shares in Q3 2019, an estimated $12.6M.
  • OrbiMed first reported a position in ProQR Therapeutics in Q3 2014 and held it in 20 quarters.
  • OrbiMed's ProQR Therapeutics position peaked at $40.1M in Q1 2015.
  • 50 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q3 2019.

Based on OrbiMed's 13F filing for Q3 2019, filed 14 Nov 2019.